Position history for BAKER BROS. ADVISORS LP's holdings in RHYTHM PHARMACEUTICALS INC
BAKER BROS. ADVISORS LP holds 5.6M shares of RYTM (RHYTHM PHARMACEUTICALS INC), worth $487.4M as of 2026-Q1. RYTM represents 2.8% of BAKER BROS. ADVISORS LP's portfolio.
Current Value
$487.4M
Current Shares
5.6M
Total Value Change
+$224.7M
Total Shares Change
-793,882
Other major holders of RYTM: BNP PARIBAS FINANCIAL MARKETS, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, RA CAPITAL MANAGEMENT, L.P.
Unchanged |
| 5.6M |
0.0% |
| $487.4M |
| 2.8% |
| $89.56 |
0 |
| 2025-Q4 | Unchanged | 5.6M | 0.0% | $599.9M | 3.5% | $106.76 | 0 |
| 2025-Q3 | Unchanged | 5.6M | 0.0% | $566M | 4.1% | $100.64 | 0 |
| 2025-Q2 | Unchanged | 5.6M | 0.0% | $354.1M | 3.4% | $62.73 | 0 |
| 2025-Q1 | Decreased | 5.6M | -7.9% | $296.9M | 3.3% | $54.80 | 0 |
| 2024-Q4 | Decreased | 6.1M | -4.9% | $340.6M | 3.6% | $56.34 | 0 |
| 2024-Q3 | Increased | 6.4M | 0.0% | $335.2M | 3.5% | $51.35 | 57 |
| 2024-Q2 | Unchanged | 6.4M | 0.0% | $262.7M | 3.4% | $41.06 | 0 |